THE RIGHT RESULTS, THE FIRST TIME

Avoid inefficiencies with a 93% first-pass yield1

When important patient care decisions are on the line, you need results you can count on—the first time. The DxH 900 hematology analyzer first-pass yield enables predictable costs and maximizes staff time by:   

› Delivering accurate results with fewer reruns using near native-state cellular characterization and DataFusion technology—a unique combination of  multiple testing methods for precise, high-resolution analysis in a single run

› Ensuring predictable costs through industry-leading 93% first-pass throughput1 for accurate flagging and a reduced number of slide reviews

› Maximizing staff time by reducing the time and supply costs related to   managing systems with higher repeat rates,
and simplifying workflow through a lean reagent portfolio 

For more information visit us at Medlab Middle East stand: Z5.F10 or www.beckmancoulter.com